Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma.
OBJECTIVE
Fibrosis and/or cirrhosis are present in the precursor stages of most liver cancers. However, little is known about the reciprocal interactions of fibroblasts, mainly responsible for fibrosis, and the other liver cells. We report here the isolation of a new liver myofibroblast cell line from a human liver angiosarcoma and its characterization.


METHODS
The cells were isolated by the explant technique and characterization was performed, on one hand, using immunohistochemical and ultrastructural analysis and, in the other hand, by determining their karyotype, ras and p53 status and their tumorigenic properties.


RESULTS
To date, the cells have undergone approximately 170 population doublings and are still proliferating. Immunohistochemically, they were negative for desmin, smooth muscle myosin, cytokeratin 19 and von Willebrand factor, positive for vimentin and alpha-smooth muscle actin, with an important deposition of fibronectin around the cells. Ultrastructure showed particularly cytoplasmic microfilament bundles. Their chromosome number ranged from 38 to 168 with a bimodal population, near diploid and hypotetraploid. No mutations were found in codons 12, 13 or 61 of Ha-, Ki- and N-ras genes but a homozygous missense mutation in codon 179 (CAT-->CTT) was detected in the p53 gene. They were unable to form foci in soft agar or tumors in nude mice.


CONCLUSIONS
Taken together, these results show that these cells, called BM 2.2.1, exhibited typical myofibroblast-like features. Although they contained a karyotype suggestive of tumoral cells and a homozygous mutated p53 gene, they were not tumorigenic. The nature of these cells and the abnormalities of the p53 gene and the karyotype, suggest that: i) they were a component of the tumor stroma, and ii) they could have been involved in angiosarcoma development. Thus, this cell line may be valuable for the study of cellular interactions in liver carcinogenesis.
Boivin-Angele
S
S
Institut National de la Santé et de la Recherche Médicale, Unité 271, Lyon, France.
Pedron
S
S
Bertrand
S
S
Desmouliere
A
A
Martel-Planche
G
G
Lefrançois
L
L
Bancel
B
B
Trépo
C
C
Marion
M J
MJ
D000818:Animals; D002461:Cell Line, Transformed; D005347:Fibroblasts / Q000473:pathology; D006394:Hemangiosarcoma / Q000235:genetics / Q000473:pathology*; D006801:Humans; D007621:Karyotyping; D008113:Liver Neoplasms / Q000235:genetics / Q000473:pathology*; D008297:Male; D051379:Mice; D008875:Middle Aged; D014407:Tumor Cells, Cultured